Tweet COCONUT CREEK, Fla.–(BUSINESS WIRE)–Greyson International Inc. (OTC Pink Sheets:GYSN), developer of an innovative patented trans-dermal and topical delivery emulsion targeting the multi-billion dollar anti-aging and OTC pharmaceutical